FDC peers

·Pharma & HealthChart ›

Companies like FDClatest year

FDCFDC · FY26 · this company
Market cap₹6,131
P/E21.78×
Sales growth+21.0%
ROE11.8%
IOL Chemicals and PharmaceuticalsIOLCP · FY26
Open ›
Market cap₹5,302
P/E38.51×
Sales growth+37.1%
ROE7.9%
Morepen LaboratoriesMOREPENLAB · FY26
Open ›
Market cap₹6,881
P/E72.59×
Sales growth+81.4%
ROE7.9%
Innova CaptabINNOVACAP · FY26
Open ›
Market cap₹6,007
P/E41.95×
Sales growth+33.9%
ROE14.0%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FDC₹376.55

FDC Limited

· Pharma & Health
₹ CrorePeersIOLCPMOREPENLABINNOVACAPORCHPHARMASENORESGUJTHEMRPGLIFESANOFIMcap ₹6,131 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
FDC
FY26
IOLCP
FY26
MOREPENLAB
FY26
INNOVACAP
FY26
Peer
Average
Valuation — at last close
P/E◆ 21.78×38.51×72.59×41.95×51.02× -57%
P/B◆ 2.47×2.95×5.52×5.55×4.67× -47%
EV/EBITDA◆ 16.20×19.45×55.60×25.96×33.67× -52%
Market Cap₹6,131 Cr₹5,302 Cr₹6,881 Cr₹6,007 Cr₹6,063 Cr +1%
Growth
Revenue CAGR 3Y6.77%1.51%◆ 8.40%—4.96% +37%
Revenue CAGR 5Y◆ 10.24%—8.73%—8.73% +17%
Net Income CAGR 3Y13.23%-0.36%◆ 34.87%—17.25% -23%
Revenue YoY (latest Q)20.95%37.08%◆ 81.38%33.94%50.80% -59%
Net Income YoY (latest Q)72.92%89.80%◆ 117.48%42.27%83.18% -12%
Profitability
EBITDA Margin◆ 15.94%11.60%6.96%14.90%11.15% +43%
Net Income Margin◆ 12.96%5.94%5.25%8.78%6.66% +95%
Return on Common Equity11.81%7.90%7.90%◆ 14.03%9.94% +19%
Return on Capital Employed11.69%10.29%6.55%◆ 15.38%10.74% +9%
Return on Assets◆ 9.99%5.54%5.11%8.38%6.34% +57%
Credit & Quality
Total Debt/Equity◆ 0.00×0.07×0.16×0.32×0.18× -100%
Interest Coverage◆ 57.54×12.97×5.43×11.70×10.03× +473%
Scale — latest FY
Revenue / Total Income₹2,171 Cr₹2,319 Cr₹1,806 Cr₹1,630 Cr₹1,918 Cr +13%
Net Income₹281 Cr₹138 Cr₹94.9 Cr₹143 Cr₹125 Cr +125%
Total Assets₹2,919 Cr₹2,587 Cr₹1,936 Cr₹1,838 Cr₹2,120 Cr +38%
EPS₹17.29₹4.69₹1.73₹25.02₹10.48 +65%
Book Value per Share₹152.64₹61.27₹22.75₹188.99₹91 +68%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.